We have investigated the impact of signaling by RAC1, an oncogene which is mutationally activated in 4% of melanomas and may be activated by alterations in upstream regulators in a larger fraction, showing that RAC1P29S promotes the initiation of melanoma driven by mutant BRAF or NF1 loss. The gene discussed is NF1; the disease is melanoma.